Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mingzhen Yang
Mechanisms Underlying the Increased Chemosensitivity of Bortezomib-Resistant Multiple Myeloma by Silencing Nuclear Transcription Factor Snail1
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
Establishment of a Bortezomib-Resistant Chinese Human Multiple Myeloma Cell Line: MMLAL
Cancer Cell International
Cancer Research
Oncology
Genetics
A Dose Increased Once-Weekly Bortezomib-Based Combination Therapy for Multiple Myeloma
Oncotarget
Oncology
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
The Nuclear Factor (Erythroid-Derived 2)-Like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Signaling Mechanisms of Bortezomib in TRAF3-deficient Mouse B Lymphoma and Human Multiple Myeloma Cells
Leukemia Research
Cancer Research
Oncology
Hematology
Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma
Core Evidence
Medicine
Reviews
References
Pharmacology
Regulation of Neural Gene Transcription by Optogenetic Inhibition of the RE1-silencing Transcription Factor
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics